Skip to content
info@ibsgranada.es
FacebookTwitterLinkedInInstagramYouTube
ibs logo.GRANADA
  • ibs.GRANADA
  • The Institute
    • The Institute
    • Organizational structure
    • Management Units
    • Economic information
    • Centers
    • Responsible Research and Innovation (RRI)
    • Researcher Area
    • Annual Reports ibs.GRANADA
    • Webmail access
    • Transparency
  • Research
    • Own Plan ibs.GRANADA
    • Research Areas
    • Research groups
    • Clinical research
    • Collaboration network between groups of the ibs.GRANADA
    • Researcher Finder
    • Publications Search
  • Innovation
    • Innovation
    • Technology Offers
    • Clinical practice guidelines
  • International
    • International Projects Unit
    • International Projects
    • International Networks
  • Training
    • Training
    • Research Sessions
    • Conferences and Courses
    • Mentoring Program ibs.GRANADA
    • PhD Programs
    • Official University Master's Degrees
  • Today
    • Calls for applications
    • News
    • Events
  • Job vacancies
    • Job vacancies
    • Human Resources Strategy for Researchers of the European Commission (HRS4R)
  • Digital Platforms

Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response

FI: 7,5
Type: Article

Home · TEC16-Advanced Therapies: Differentiation, Regeneration and Cancer

Collaboration

Year: 2023

Brands

Ruiz-Malagón, AJ; Hidalgo-García, L; Rodríguez-Sojo, MJ; Molina-Tijeras, JA; García, F; Diez-Echave, P; Vezza, T; Becerra, P; Marchal, JA; Redondo-Cerezo, E; Hausmann, M; Rogler, G; Garrido-Mesa, J; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Gálvez, J

Magazine

Title: BIOMEDICINE & PHARMACOTHERAPY

Quartile

  • Q1
facebook icon twitter icon LinkedIn icon whatsapp icon

Read the article


View in PubMed


See in DOI

Post navigation

Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature
Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 ​​Weeks) in Three Tertiary Hospitals in Andalucia (Spain)

ibs.Granada logo

  • info@ibsgranada.es
  • Avda. De Madrid, 15
    External Consultation Pavilion, 2nd Floor
    18012 Grenada.
  • facebook icon
  • twitter icon
  • instagram icon
  • linkedin icon
  • youtube icon
University of Granada
Investigate +
© 2025 ibs.GRENADA
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Contact
  • Site map

We use cookies to offer you the best experience on our website.

You can learn more about which cookies we use or deactivate them in the .

X
ibs logo.GRANADA
Powered by  GDPR Cookie Compliance
Privacy summary

This website uses cookies so that we can offer you the best possible user experience. The information of the cookies is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.

Technical and necessary cookies

The strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

Analytics and optimization

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Cookies policy

More information about our Cookies policy